|
RNA | Avidity Biosciences, Inc. |
|
|
RNA | Avidity Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.62 |
| Leverage | 8.90% |
| Market Cap | $ 2.6B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -368.1m |
| Margin | -4429.40% |
Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.